• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[乳腺癌石蜡切片中雌激素和孕激素受体的免疫组织化学评估。基于368例研究的实践思考]

[Immunohistochemical evaluation of estrogen and progesterone receptors on paraffin sections of breast carcinomas. Practical thoughts based on the study of 368 cases].

作者信息

Balaton A J, Baviera E E, Galet B, Vaury P, Vuong P N

机构信息

Centre de Pathologie, Bièvres.

出版信息

Arch Anat Cytol Pathol. 1995;43(1-2):93-100.

PMID:7794034
Abstract

368 formalin-fixed and paraffin-embedded carcinomas of the breast were studied by immunohistochemistry using antibodies to estrogen and progesterone receptors. The results, which are comparable to the results published in the literature, are discussed with particular emphasis on quality assurance parameters.

摘要

采用雌激素和孕激素受体抗体，通过免疫组织化学方法对368例福尔马林固定石蜡包埋的乳腺癌组织进行了研究。研究结果与文献报道结果相当，并特别强调质量保证参数进行了讨论。

相似文献

1
[Immunohistochemical evaluation of estrogen and progesterone receptors on paraffin sections of breast carcinomas. Practical thoughts based on the study of 368 cases].[乳腺癌石蜡切片中雌激素和孕激素受体的免疫组织化学评估。基于368例研究的实践思考]
Arch Anat Cytol Pathol. 1995;43(1-2):93-100.
2
[Recommendations for the immunohistochemistry of the hormonal receptors on paraffin sections in breast cancer. Update 1999. Group for Evaluation of Prognostic Factors using Immunohistochemistry in Breast Cancer (GEFPICS-FNCLCC)].
Ann Pathol. 1999 Sep;19(4):336-43.
3
[Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology].
Ann Pathol. 1996;16(2):144-8.
4
[Human breast cancer embedded in paraffin, fixed in Bouin's fluid. Immunohistochemical analysis of estrogen and progesterone receptors].[嵌入石蜡的人乳腺癌组织，用布因氏液固定。雌激素和孕激素受体的免疫组织化学分析]
Ann Pathol. 1991;11(4):224-30.
5
[Estrogen and progesterone receptors of primary breast carcinoma and their axillary lymph node metastases--immunohistochemical investigations of routine formalin-fixed paraffin-embedded tissue].[原发性乳腺癌及其腋窝淋巴结转移灶的雌激素和孕激素受体——常规福尔马林固定石蜡包埋组织的免疫组织化学研究]
Zentralbl Gynakol. 2000;122(2):92-5.
6
Primary breast carcinoma: immunocytochemical and immunohistochemical evaluation of biological parameters.原发性乳腺癌：生物学参数的免疫细胞化学和免疫组织化学评估
Chir Ital. 2000 Nov-Dec;52(6):643-5.
7
Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies.雄激素受体在乳腺癌中经常表达：对新治疗策略的潜在意义。
Cancer. 2003 Aug 15;98(4):703-11. doi: 10.1002/cncr.11532.
8
[A study on immunohistochemical detection of estrogen receptor in the breast cancer tissue--a comparison between routinely paraffin-embedded and frozen sections].
Rinsho Byori. 1995 Sep;43(9):960-4.
9
Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.使用新型兔单克隆抗体SP1和SP2对乳腺癌细针穿刺抽吸物和石蜡包埋切片中的激素受体状态进行评估。
Diagn Cytopathol. 2003 Oct;29(4):207-11. doi: 10.1002/dc.10365.
10
Evaluation of oestrogen and progesterone receptors, and c-erbB-2 in carcinoma of the breast in Trinidadian women.特立尼达女性乳腺癌中雌激素和孕激素受体以及c-erbB-2的评估。
West Indian Med J. 2002 Mar;51(1):4-9.

引用本文的文献

1
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study.激素受体阳性乳腺癌中基于依维莫司治疗反应的免疫系统及血管生成相关潜在替代生物标志物：一项探索性研究
Breast Cancer Res Treat. 2020 Nov;184(2):421-431. doi: 10.1007/s10549-020-05856-3. Epub 2020 Aug 7.
2
Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis.管腔样HER2阴性IA期乳腺癌：一项采用倾向评分分析的长期结局多中心回顾性研究。
Oncotarget. 2017 Nov 24;8(68):112816-112824. doi: 10.18632/oncotarget.22643. eCollection 2017 Dec 22.
3
Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy.
接受新辅助化疗的乳腺癌患者的时间变化效应和长期生存分析。
Br J Cancer. 2015 Jun 30;113(1):30-6. doi: 10.1038/bjc.2015.174. Epub 2015 Jun 16.
4
Epigenomic alterations in breast carcinoma from primary tumor to locoregional recurrences.乳腺癌中从原发性肿瘤到局部区域复发的表观基因组改变。
PLoS One. 2014 Aug 6;9(8):e103986. doi: 10.1371/journal.pone.0103986. eCollection 2014.
5
Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma.在 HR 阳性/HER2 阴性乳腺癌中，诊断核心活检与相应手术标本的组织学分级一致性。
Br J Cancer. 2014 Apr 29;110(9):2195-200. doi: 10.1038/bjc.2014.143. Epub 2014 Apr 8.
6
Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma.Ki67 率在早期、pT1-pT2、pN0、浸润性乳腺癌中的长期预后性能。
PLoS One. 2013;8(3):e55901. doi: 10.1371/journal.pone.0055901. Epub 2013 Mar 19.